Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_assertion type Assertion NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_head.
- NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_assertion description "[Perfusion with the selective P450 epoxygenase inhibitor N-methylsulphonyl-6-(2-proparglyloxyphenyl)hexanamide (MS-PPOH) for 20 minutes before ischemia results in reduced postischemic LVDP recovery in WT hearts and abolishes the improved postischemic LVDP recovery in CYP2J2 Tr hearts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_provenance.
- NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_assertion evidence source_evidence_literature NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_provenance.
- NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_assertion SIO_000772 15256482 NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_provenance.
- NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_assertion wasDerivedFrom befree-20150227 NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_provenance.
- NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_assertion wasGeneratedBy ECO_0000203 NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_provenance.